Isomorphic Labs nears 2 billion funding boost to supercharge AI drug design engine

Published on 9 May 2026

Thrive Capital is reportedly leading the push

Alphabet’s AI drug discovery startup Isomorphic Labs is reportedly close to raising more than $2 billion in new funding led by Thrive Capital. The fresh cash is set to expand its AI drug design engine and support global growth, reinforcing Alphabet’s push to commercialize advanced AI technology beyond research labs.

Isomorphic Labs is reportedly nearing $2 billion in new funding
Thrive Capital is said to be leading the investment round
The money will strengthen its AI drug design engine
Global expansion is a key goal for the startup

#alphabet #startup funding #ai drug discovery #isomorphic labs #thrive capital

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Isomorphic Labs nears 2 billion funding boost to supercharge AI drug design engine

The full experience is on mobile.